R-90118 Senior Director - API Operations (NOT REMOTE - NEW SITE) at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

API ManufacturingGMP SystemsOrganizational DevelopmentLeadershipOperational ReadinessProcess DevelopmentSafety CultureStrategic Direction

Questions & Answers

Common questions about this position

Is this position remote or onsite?

This position is not remote and requires onsite work at the new manufacturing site.

What is the salary range for this Senior Director role?

This information is not specified in the job description.

What are the key responsibilities during the pre-startup and startup phase?

Key responsibilities include leading operational readiness and startup, building the manufacturing organization with capability, capacity, and culture for safety, quality, and excellence, developing GMP systems and processes, embedding lean principles, and acting as end-user representative during project delivery.

What is the company culture like at this new manufacturing site?

The role involves shaping site culture to achieve high standards in safety, quality, and operational excellence, embedding lean principles and a continuous improvement mindset, while putting people first and aligning with long-term business goals.

What makes a strong candidate for this Senior Director position?

Strong candidates should have leadership experience in manufacturing operations for small molecule or siRNA/oligonucleotide, ability to build organizations and culture for GMP startup, expertise in lean principles and continuous improvement, and skills in cross-functional collaboration and strategic planning.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free